Cargando…
Rapid Identity and Quantity CQA Test for Multivalent mRNA Drug Product Formulations
The COVID-19 pandemic highlighted mRNA as a promising platform for vaccines and therapeutics. Many of the analytical tools used to characterize the critical quality attributes of mRNA are inherently singleplex and are not necessarily optimal from a labor and cost perspective. Here, we demonstrate th...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612012/ https://www.ncbi.nlm.nih.gov/pubmed/36298569 http://dx.doi.org/10.3390/vaccines10101704 |